BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence ("AI") and machine learning to enable the ...

EsoGuard test could get Medicare coverage soon, according to recent commentary from BTIG analysts. Analysts at BTIG said that during a day of investor meetings with Lucid’s executive team, it became ...

The stock market may soon face a pullback based on technical indicators, according to Jonathan Krinsky, managing director and chief market technician at BTIG. The S&P 500 is on track to close above ...

CALABASAS, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central ...

Kirby Corporation (NYSE:KEX) is one of the best shipping and container stocks to invest in now. On June 27, analyst Gregory ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today announced that Steve ...

BTIG announced today that it will hold its annual Biotechnology Conference on Tuesday, July 29th through Wednesday, July 30th, 2025. The virtual event will host over 70 established and emerging ...

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best oversold NASDAQ stocks to buy now. On July 11, BTIG analyst Julian ...

BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...

BTIG announced today that the virtual BTIG Obesity Health Forum will take place on Wednesday, June 18, 2025. The forum will bring together experts, innovator ...